Literature DB >> 9030418

Brain lactate, not glucose, fuels the recovery of synaptic function from hypoxia upon reoxygenation: an in vitro study.

A Schurr1, R S Payne, J J Miller, B M Rigor.   

Abstract

Lactate has been considered for many years to be a useless, and frequently, harmful end-product of anaerobic glycolysis. In the present in vitro study, lactate-supplied rat hippocampal slices showed a significantly higher degree of recovery of synaptic function after a short hypoxic period than slices supplied with an equicaloric amount of glucose. More importantly, all slices in which anaerobic lactate production was enhanced by pre-hypoxia glucose overload exhibited functional recovery after a prolonged hypoxia. An 80% recovery of synaptic function was observed even when glucose utilization was blocked with 2-deoxy-D-glucose during the later part of the hypoxic period and during reoxygenation. In contrast, slices in which anaerobic lactate production was blocked during the initial stages of hypoxia did not recover their synaptic function upon reoxygenation despite the abundance of glucose and the removal of 2-deoxy-D-glucose. Thus, for brain tissue to show functional recovery after prolonged period of hypoxia, the aerobic utilization of lactate as an energy substrate is mandatory.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9030418     DOI: 10.1016/s0006-8993(96)01106-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  62 in total

1.  A method for producing regional hypoglycemia in blood perfused tissue.

Authors:  B J Hart; X Bian; A G Williams; H F Downey
Journal:  Mol Cell Biochem       Date:  1999-10       Impact factor: 3.396

2.  Intermediate zone cells express calcium-permeable AMPA receptors and establish close contact with growing axons.

Authors:  C Métin; J P Denizot; N Ropert
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

3.  Dual-gene, dual-cell type therapy against an excitotoxic insult by bolstering neuroenergetics.

Authors:  Tonya M Bliss; Miranda Ip; Elise Cheng; Masabumi Minami; Luc Pellerin; Pierre Magistretti; Robert M Sapolsky
Journal:  J Neurosci       Date:  2004-07-07       Impact factor: 6.167

4.  Neurons and neuronal stem cells survive in glucose-free lactate and in high glucose cell culture medium during normoxia and anoxia.

Authors:  Sascha Wohnsland; Heinrich F Bürgers; Wolfgang Kuschinsky; Martin H Maurer
Journal:  Neurochem Res       Date:  2010-07-03       Impact factor: 3.996

Review 5.  How astrocytes feed hungry neurons.

Authors:  Luc Pellerin
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

6.  Monocarboxylate transporter 2 and stroke severity in a rodent model of sleep apnea.

Authors:  Yang Wang; Shang Z Guo; Arend Bonen; Richard C Li; Leila Kheirandish-Gozal; Shelley X L Zhang; Kenneth R Brittian; David Gozal
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

7.  Neurometabolic coupling between neural activity, glucose, and lactate in activated visual cortex.

Authors:  Baowang Li; Ralph D Freeman
Journal:  J Neurochem       Date:  2015-05-29       Impact factor: 5.372

8.  Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors.

Authors:  Anna Maria Pugliese; Serena Latini; Renato Corradetti; Felicita Pedata
Journal:  Br J Pharmacol       Date:  2003-08-11       Impact factor: 8.739

9.  Acidosis mediates recurrent hypoglycemia-induced increase in ischemic brain injury in treated diabetic rats.

Authors:  Ashish K Rehni; Vibha Shukla; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  Neuropharmacology       Date:  2018-03-15       Impact factor: 5.250

10.  Half-molar sodium-lactate solution has a beneficial effect in patients after coronary artery bypass grafting.

Authors:  Xavier M Leverve; Cindy Boon; Tarmizi Hakim; Maizul Anwar; Erwin Siregar; Iqbal Mustafa
Journal:  Intensive Care Med       Date:  2008-06-18       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.